Skip to main content

Submit a technology commercialization grant pre-proposal >>

About Us
Grants
Startup Investments
- Investing in Washington
- Active Portfolio & Exits
Stories
News
- Articles
- Videos
- Reports
Contact

Keywords:

Anindya Roy receives $250,000 from Washington Research Foundation to develop inhaled protein therapeutic for IPF

Post navigation

← Meridian Group International and Skytap enter into a Global Alliance Partnership to Help Customers Migrate Their IBM Power Workloads to Microsoft Azure Seattle-based Icosavax, which is developing COVID-19 vaccines, files for IPO 4 years after launch →

Comments are closed.

Home
Contact

About Us

Grants

Startup Investments
- Investing in Washington
- Active Portfolio & Exits

News
- Articles
- Videos
- Stories

LinkedIn
Twitter

Washington Research Foundation values diversity. We’re committed to diversity, equity and inclusion in our staff, our board of directors, and the researchers, entrepreneurs and organizations we fund. We encourage people of color, women and other underserved communities to apply for our employment, grant-making and investment opportunities.

© 2023 Washington Research Foundation, Seattle WA

Terms of Use
Privacy Policy
(206) 336-5600
Site by The Medium

About Us
Grants
Startup Investments
- Investing in Washington
- Active Portfolio & Exits
Stories
News
- Articles
- Videos
- Reports
Contact